Relationship of N-demethylation of amiflamine and its metabolite to debrisoquine hydroxylation polymorphismALVAN, G; GRIND, M; GRAFFNER, C et al.Clinical pharmacology and therapeutics. 1984, Vol 36, Num 4, pp 515-519, issn 0009-9236Article

Increased total activity in the rat after L-tryptophan plus the monoamine oxidase-A inhibitor amiflamine but not after L-tryptophan plus clorgylineARCHER, T; FOWLER, C. J; FREDRIKSSON, A et al.British journal of pharmacology. 1985, Vol 85, Num 3, pp 581-590, issn 0007-1188Article

Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenumASK, A.-L.Naunyn-Schmiedeberg's archives of pharmacology. 1984, Vol 327, Num 1, pp 56-63, issn 0028-1298Article

The effects of amiflamine, a reversible MAO-A inhibitor, on the first pass metabolism of tyramine in dog intestineYASAHURA, H; KIUCHI, Y; OGUCHI, K et al.Japanese journal of pharmacology. 1986, Vol 41, Num 4, pp 505-510, issn 0021-5198Article

Inhibition of monoamine oxidase A-form and semicarbazide sensitive amine-oxidase by selective and reversible monoamine oxidase-A inhibitors, amiflamine and FLA 788(+)MORIKAWA, F; UEDA, T; ARAI, Y et al.Pharmacology. 1986, Vol 32, Num 1, pp 33-45, issn 0031-7012Article

Selection of precipitation medium for drug substances as a part of a preformulation program for tablet formulationsNYQVIST, H; GRAFFNER, C.Acta pharmaceutica suecica. 1986, Vol 23, Num 5, pp 257-270, issn 0001-6675Article

The effects of manipulation of presynaptic 5-HT nerve terminals on postsynaptic 5-HT₁ and 5-HT₂ binding sites of the rat brainHALL, H; WEDEL, I.Journal of neural transmission. 1985, Vol 64, Num 2, pp 129-143, issn 0300-9564Article

Effects of amiflamine and related compounds on the accumulation of biogenic monoamines in rat brain slices in vitro and ex vivo in relation to their behavioural effectsRENYI, L; ROSS, S. B.Acta pharmacologica et toxicologica. 1985, Vol 56, Num 5, pp 416-426, issn 0001-6683Article

Aggression in female mice : contrasting effects of amiflamine (FLA 336), a selective and reversible MAO-Type A inhibitorWALLIAN, L; BRAIN, P. F; HAUG, M et al.Physiology & behavior. 1993, Vol 54, Num 2, pp 411-414, issn 0031-9384Article

Selective inhibition of monoamine oxidase by p-aminosubstituted phenylalkylamines in catecholaminergic neuronesASK, A.-L; FAGERVALL, I; FLORVALL, L et al.Neuropharmacology. 1986, Vol 25, Num 1, pp 33-40, issn 0028-3908Article

Release of ³H-5-hydroxytryptamine by amiflamine and related phenylalkylamines from rat occipital cortex slicesASK, A.-L; FAGERVALL, I; RU-BIN HUANG et al.Naunyn-Schmiedeberg's archives of pharmacology. 1989, Vol 339, Num 6, pp 684-689, issn 0028-1298Article

The inhibition of the cage-leaving response. A model for studies of the serotonergic neurotransmission in the ratRENYI, L; ARCHER, T; MINOR, B. G et al.Journal of neural transmission. 1986, Vol 65, Num 3-4, pp 193-210, issn 0300-9564Article

Cortical β- and α₁-adrenoceptor binding, hypothalamic noradrenaline and pineal melatonin concentrations measured at different times of the day after repeated treatment of rats with imipramine, zimeldine, alaproclate and amiflamineASK, A.-L; FOWLER, C. J; HALL, H et al.Acta pharmacologica et toxicologica. 1986, Vol 58, Num 1, pp 16-24, issn 0001-6683Article

Effect of repeated amiflamine administration on serotonergic and noradrenergic neurotransmission: electrophysiological studies in the rat CNSBLIER, P; DE MONTIGNY, C; AZZARO, A. J et al.Naunyn-Schmiedeberg's archives of pharmacology. 1986, Vol 334, Num 3, pp 253-260, issn 0028-1298Article

Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brainASK, A.-L; FAGERVALL, I; ROSS, S. B et al.Naunyn-Schmiedeberg's archives of pharmacology. 1983, Vol 234, Num 2, pp 79-87, issn 0028-1298Article